Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Morphine antibody (HRP)

ELISA Host: Rabbit Polyclonal HRP
Catalog No. ABIN676802
  • Target See all Morphine products
    Morphine
    Reactivity
    Please inquire
    Host
    • 16
    • 4
    • 3
    • 1
    Rabbit
    Clonality
    • 16
    • 8
    Polyclonal
    Conjugate
    • 16
    • 3
    • 2
    • 1
    • 1
    • 1
    This Morphine antibody is conjugated to HRP
    Application
    • 20
    • 6
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA
    Purification
    Purified by Protein A.
    Immunogen
    KLH conjugated Morphine
    Isotype
    IgG
  • Application Notes
    IHC-P 1:100-500
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
    Preservative
    Gentamicin sulfate
    Precaution of Use
    This product contains Gentamicin sulfate: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handling Advice
    Do NOT add Sodium Azide! Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase.
    Storage
    -20 °C
    Storage Comment
    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
    Expiry Date
    12 months
  • Target
    Morphine
    Abstract
    Morphine Products
    Target Type
    Chemical
    Background

    Synonyms: Morphine 6.

    Background: Morphine is thought to produce reinforcement phenomena via stimulation of mu, delta, and kappa opioid receptors that regulate stress perception, pain control, reward behavior, and neurohormone secretion in reward-relevant brain systems. It has the highest affinity for mu, followed by delta and kappa. Rapid activation of the mu opioid receptor by morphine results in a euphoric phenotype, thus conferring the reinforcing effects of the drug. This activation is accompanied by extracellular dopamine release, which alters several events related to the cAMP signal transduction pathway. Of particular significance is that CREB seems to be modified by morphine, thereby affecting addictive behavioral phenomena, such as withdrawal symptoms.

You are here:
Support